Search CROs

• Analytical Method Development & Validation
• Biomarker Assays
• Computational & In-Silico Drug Discovery

Boston-based CRO specializing in assay development and biochemical & cellular screening for early-stage drug discovery, from target validation through lead optimization.

• Genetic Toxicology
• GLP Toxicology
• In Vitro ADME / DMPK

GLP-compliant nonclinical CRO specializing in safety and toxicology testing across in silico, in vitro, and in vivo modalities, with 35+ years of experience and nearly 6,000 completed studies.

• Analytical Method Development & Validation
• Bioanalysis
• Discovery Research

Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.

• DART (Reproductive & Developmental Toxicology)
• GLP Toxicology
• In Vivo Efficacy Models

Europe-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Clinical Research Organization offering Phase I–IV clinical trials, pharmacovigilance, medical writing, regulatory affairs, and data management services with 15+ years of experience across cardiology, oncology, vaccines, and medical devices.

• Bioanalysis
• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services

Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.

• Flow Cytometry Services
• In Vitro ADME / DMPK
• In Vitro Pharmacology

JangoCell provides contract cell expansion, flow cytometry, cell sorting, and molecular biology services for researchers, with expertise in both 2D and 3D bioreactor-based culture systems scaling to billions of cells.

• Analytical Method Development & Validation
• Bioanalysis
• Genetic Toxicology

Canada's largest privately owned CRO specializing in GMP and GLP testing for pharmaceutical, biologic, and medical device companies. Offers analytical chemistry, microbiology, toxicology, bioanalytical, and genetic toxicology services with over 50 years of experience.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

European-based full-service CRO supporting biotech and medtech companies from Phase I through Phase IV and market access, with 80+ senior clinical research associates across Europe and the USA.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Clinical Operations

Veranex is an Innovation CRO uniting design, preclinical, clinical, regulatory, and market-access expertise for medical devices and diagnostics. The company accelerates development from concept through commercialization with integrated cross-disciplinary teams across 15 international hubs.

• Biostatistics & Statistical Programming
• Clinical Operations
• Data Management & eClinical

Integrated biometrics CRO delivering clinical data management, biostatistics, statistical programming, and medical writing with AI augmentation and GxP validation for biotech sponsors across all phases of clinical development.

• Computational & In-Silico Drug Discovery
• Discovery Research
• High-Throughput Screening

Preclinical drug discovery CRO combining proprietary generative AI platform AxDrug with computational chemistry, synthetic chemistry, and in vitro biology to accelerate hit discovery and lead optimization for biotech and pharma clients.

• Bioanalysis
• Biomarker Assays
• In Vitro ADME / DMPK

Specialized preclinical CRO offering in vitro and in vivo kidney disease models, histology services, and biomarker analysis for renal and fibrotic disease drug development.

CRAMSN is a contract research, development, and manufacturing organization (CRO/CDMO/CMO) offering end-to-end solutions for drug substance and drug product development with GMP-certified facilities recognized by US, EU, Japan, and Canada regulatory authorities.

• Medical Writing
• Preclinical In Vitro Studies
• Preclinical In Vivo Studies

Cadena Research is a CRO specializing in preclinical development of radiopharmaceuticals, offering laboratory services, radiochemistry expertise, regulatory guidance, and scientific advisory support to accelerate drug development and approval.

• Computational & In-Silico Drug Discovery
• Discovery Research
• Medicinal Chemistry

Medicinal chemistry CRO specializing in custom lipid synthesis, stable isotope labeling, hit-to-lead optimization, and process development for pharmaceutical and biotech clients since 2006.

• In Vitro ADME / DMPK
• Preclinical In Vitro Studies
• Safety Pharmacology

GLP-accredited in vitro CRO specializing in OECD-validated skin corrosion, skin irritation, and ocular irritation testing using reconstructed human tissue models. Serves pharmaceutical, cosmetic, chemical, and medical device companies with non-animal alternatives for REACH, CLP, cosmetics, and FDA submissions.

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

Full-service CRO headquartered in Cairo, Egypt, providing clinical research services across phases I–IV with regional expertise in MENA and Africa, including feasibility assessment and publication support.